GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (STU:0IT) » Definitions » YoY EPS Growth

Satellos Bioscience (STU:0IT) YoY EPS Growth : 39.02% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Satellos Bioscience's YoY EPS Growth for the quarter that ended in Dec. 2024 was 39.02%.

Satellos Bioscience's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was €-0.03.

Satellos Bioscience YoY EPS Growth Historical Data

The historical data trend for Satellos Bioscience's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience YoY EPS Growth Chart

Satellos Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
- -1,329.03 49.89 44.59 236.59

Satellos Bioscience Quarterly Data
Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.44 -51.85 2.86 -152.38 39.02

Satellos Bioscience YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Satellos Bioscience's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(0.168--0.123)/ | -0.123 |
=236.59 %

Satellos Bioscience's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(-0.025--0.041)/ | -0.041 |
=39.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satellos Bioscience YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (STU:0IT) » Definitions » YoY EPS Growth
Comparable Companies
TSXV:ARCH TSX:MDNA XCNQ:GLAB TSX:ONC TSXV:COV XCNQ:ONCO TSXV:MIR TSX:SVA TSXV:NRX TSXV:SHRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
MSCLF:USA 0ITA:Germany MSCL:Canada
Address
200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Website
https://www.satellos.com
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience Headlines

No Headlines